SHIFT Newsroom · GLOBAL
Trial record: trevogrumab and garetosmab with semaglutide
Registry status checked on 3 October 2026: active not recruiting.
ClinicalTrials.gov lists NCT06299098, concerning trevogrumab and garetosmab with semaglutide, as active not recruiting. The record was first posted on 2024-03-07 and last updated on 2026-09-01; SHIFT checked it on 3 October 2026. This means the study remains active but is not currently enrolling new participants.
The protocol has separate parts involving healthy participants and participants with obesity. A single overall status does not describe every part of the study.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.